Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
P/E ratio for Option Care Health, Inc. (OPCH)
P/E ratio as of 2023: 22.58
According to Option Care Health, Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 22.58. At the end of 2022 the company had a P/E ratio of 36.20.
P/E ratio history for Option Care Health, Inc. from 1996 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | 22.58 |
| 2022 | 36.20 |
| 2021 | 36.56 |
| 2020 | -350.47 |
| 2019 | -30.71 |
| 2018 | -8.84 |
| 2017 | -5.75 |
| 2016 | -2.35 |
| 2015 | -0.40 |
| 2014 | -3.25 |
| 2013 | -6.86 |
| 2012 | 9.36 |
| 2011 | 37.80 |
| 2010 | -3.81 |
| 2009 | 6.02 |
| 2008 | -1.15 |
| 2007 | 87.73 |
| 2006 | -3.37 |
| 2005 | -10.79 |
| 2004 | 20.12 |
| 2003 | 17.07 |
| 2002 | 7.02 |
| 2001 | 26.57 |
| 2000 | -9.72 |
| 1999 | -12.19 |
| 1998 | 12.05 |
| 1997 | -4.44 |
| 1996 | -1.50 |